FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for treatment of psoriasis patients. Simvastatin monotherapy is offered therefor. Said therapy is administered during 2 months. Simvastatin is introduced in a dose 40 mg/days.
EFFECT: therapy ensures effective disease treatment with using one medicine.
2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PREDICTION PROCEDURE OF SIMVASTATIN BASED CLINICAL EFFECTIVENESS WITH REGARD TO RHEUMATOID ARTHRITIS | 2008 |
|
RU2367430C1 |
METHOD OF TREATING PATIENTS WITH PSORIASIS IN PROGRESSING STAGE | 2019 |
|
RU2716616C1 |
METHOD OF TREATING PATIENTS WITH PSORIASIS IN PROGRESSING STAGE | 2019 |
|
RU2716617C1 |
METHOD OF TREATING PATIENTS SUFFERING WINTER-TYPE PLAQUE PSORIASIS OF MODERATE AND MILD SEVERITY | 2014 |
|
RU2567725C2 |
METHOD OF TREATING PSORIASIS VULGARIS | 2011 |
|
RU2472541C1 |
METHOD OF TREATING PSORIASIS | 2009 |
|
RU2393840C1 |
METHOD OF CURE FOR ERYTHRODERMA PSORIATICUM | 2008 |
|
RU2369394C1 |
METHOD OF TREATING PSORIASIS | 2011 |
|
RU2464998C1 |
METHOD OF TREATING PSORIASIS VULGARIS | 2012 |
|
RU2476228C1 |
METHOD OF PSORIASIS TREATMENT | 2007 |
|
RU2361605C2 |
Authors
Dates
2009-09-20—Published
2007-01-30—Filed